These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37463828)

  • 1. Corrigendum to "Did the UK's public health shielding policy protect the clinically extremely vulnerable during the COVID-19 pandemic in wales? Results of EVITE immunity, a linked data retrospective study" [Public Health 218 (2023) 12-20].
    Snooks H; Watkins A; Lyons J; Akbari A; Bailey R; Bethell L; Carson-Stevens A; Dale J; Edwards A; Emery H; Evans BA; Jolles S; John A; Kingston M; Porter A; Sewell B; Williams V; Lyons RA
    Public Health; 2023 Sep; 222():229. PubMed ID: 37463828
    [No Abstract]   [Full Text] [Related]  

  • 2. Did the UK's public health shielding policy protect the clinically extremely vulnerable during the COVID-19 pandemic in Wales? Results of EVITE Immunity, a linked data retrospective study.
    Snooks H; Watkins A; Lyons J; Akbari A; Bailey R; Bethell L; Carson-Stevens A; Edwards A; Emery H; Evans BA; Jolles S; John A; Kingston M; Porter A; Sewell B; Williams V; Lyons RA
    Public Health; 2023 May; 218():12-20. PubMed ID: 36933354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the shielding initiative in Wales (EVITE Immunity): protocol for a quasiexperimental study.
    Evans BA; Akbari A; Bailey R; Bethell L; Bufton S; Carson-Stevens A; Dixon L; Edwards A; John A; Jolles S; Kingston MR; Lyons J; Lyons R; Porter A; Sewell B; Thornton CA; Watkins A; Whiffen T; Snooks H
    BMJ Open; 2022 Sep; 12(9):e059813. PubMed ID: 36691218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost of implementing the COVID-19 shielding policy in Wales.
    Sewell B; Farr A; Akbari A; Carson-Stevens A; Dale J; Edwards A; Evans BA; John A; Torabi F; Jolles S; Kingston M; Lyons J; Lyons RA; Porter A; Watkins A; Williams V; Snooks H
    BMC Public Health; 2023 Nov; 23(1):2342. PubMed ID: 38008730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale for the shielding policy for clinically vulnerable people in the UK during the COVID-19 pandemic: a qualitative study.
    Porter A; Akbari A; Carson-Stevens A; Dale J; Dixon L; Edwards A; Evans B; Griffiths L; John A; Jolles S; Kingston MR; Lyons R; Morgan J; Sewell B; Whiffen A; Williams VA; Snooks H
    BMJ Open; 2023 Aug; 13(8):e073464. PubMed ID: 37541747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the COVID-19 pandemic on the mental health of clinically extremely vulnerable children and children living with clinically extremely vulnerable people in Wales: a data linkage study.
    Cowley LE; Hodgson K; Song J; Whiffen T; Tan J; John A; Bandyopadhyay A; Davies AR
    BMJ Open; 2023 Jun; 13(6):e067882. PubMed ID: 37328187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of Shielding Behavior During the COVID-19 Pandemic and Associations With Well-being Among National Health Service Patients: Longitudinal Observational Study.
    Bachtiger P; Adamson A; Maclean WA; Kelshiker MA; Quint JK; Peters NS
    JMIR Public Health Surveill; 2021 Sep; 7(9):e30460. PubMed ID: 34298499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming health care: the policy and politics of service reconfiguration in the UK's four health systems.
    Stewart E; Greer SL; Ercia A; Donnelly PD
    Health Econ Policy Law; 2020 Jul; 15(3):289-307. PubMed ID: 30975243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mental health and life satisfaction among those advised to shield during the COVID-19 pandemic in the UK: a secondary analysis of the Understanding Society longitudinal study.
    Morris SG; Kudrna L; Martin J
    Front Public Health; 2023; 11():1235903. PubMed ID: 37829093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the impact of shielding advice on the wellbeing of individuals identified as clinically extremely vulnerable amid the COVID-19 pandemic: a mixed-methods evaluation.
    Lasseter G; Compston P; Robin C; Lambert H; Hickman M; Denford S; Reynolds R; Zhang J; Cai S; Zhang T; Smith LE; Rubin GJ; Yardley L; Amlôt R; Oliver I
    BMC Public Health; 2022 Nov; 22(1):2145. PubMed ID: 36418978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'We thank you for your sacrifice': Clinical vulnerability, shielding and biosociality in the UK's Covid-19 response.
    Herrick C
    Biosocieties; 2023; 18(1):218-240. PubMed ID: 35096124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Right to Health in Times of Pandemic: What Can We Learn from the UK's Response to the COVID-19 Outbreak?
    Montel L; Kapilashrami A; Coleman MP; Allemani C
    Health Hum Rights; 2020 Dec; 22(2):227-241. PubMed ID: 33390709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming health care: the policy and politics of service reconfiguration in the UK's four health systems - CORRIGENDUM.
    Stewart E; Greer SL; Ercia A; Donnelly PD
    Health Econ Policy Law; 2021 Jan; 16(1):111. PubMed ID: 32469299
    [No Abstract]   [Full Text] [Related]  

  • 14. Development and evaluation of a text analytics algorithm for automated application of national COVID-19 shielding criteria in rheumatology patients.
    Jani M; Alfattni G; Belousov M; Laidlaw L; Zhang Y; Cheng M; Webb K; Hamilton R; Kanter AS; Dixon WG; Nenadic G
    Ann Rheum Dis; 2024 Apr; ():. PubMed ID: 38575324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on mortality of shielding clinically extremely vulnerable patients in Liverpool, UK, during the COVID-19 pandemic.
    Filipe L; Barnett LA; Piroddi R; Buchan I; Duckworth H; Barr B
    Public Health; 2023 Sep; 222():54-59. PubMed ID: 37523949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Learning policy lessons from the pandemic: the UK's COVID Inquiry.
    McKee M
    Eur J Public Health; 2024 Feb; 34(1):5-6. PubMed ID: 38316527
    [No Abstract]   [Full Text] [Related]  

  • 17. When experts disagree: interviews with public health experts on health outcomes in the UK 2010-2020.
    Hiam L; Dorling D; McKee M
    Public Health; 2023 Jan; 214():96-105. PubMed ID: 36528937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: Effects of the COVID-19 pandemic on the mental health of clinically extremely vulnerable children and children living with clinically extremely vulnerable people in Wales: a data linkage study.
    BMJ Open; 2023 Jun; 13(6):e067882corr1. PubMed ID: 37369428
    [No Abstract]   [Full Text] [Related]  

  • 19. Using health impact assessment (HIA) to understand the wider health and well-being implications of policy decisions: the COVID-19 'staying at home and social distancing policy' in Wales.
    Green L; Ashton K; Azam S; Dyakova M; Clemens T; Bellis MA
    BMC Public Health; 2021 Jul; 21(1):1456. PubMed ID: 34315469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ending weight-related stigma as the lynchpin for tackling obesity: a comment on the contribution of the UK's policy response to obesity in the COVID-19 pandemic.
    Gibson-Miller J; Chater A
    Perspect Public Health; 2022 Jan; 142(1):15-17. PubMed ID: 34044646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.